XTNT: Xtant Medical Holdings Forvard P/E multiplikatori

xtantmedical.com (XTNT) grafik logotipi

Xtant Medical Holdings (XTNT) kompaniyasining forward P/E koeffitsiyenti uzoq muddatli biznes baholash tendentsiyasini namoyish etmoqda va joriy daraja 0.00 atrofida shakllangan. AQSH klinikalaridagi kengayish suyak implantlari uchun distribyutsiya hamkorliklari hisobiga amalga oshirilmoqda. Narxlarni belgilash imkoniyatini cheklovchi sug'urta to'lovlari limitlari foyda potentsialini jilovlamoqda. Ortopediya sektoridagi barqaror talabga qaramay, bozor bosimi va o'tmishdagi moliyaviy beqarorlik tufayli umumiy tushumlar bashorat qilinuvchanligi pasaymoqda.

Xtant Medical Holdings - XTNT Narxning kutilayotgan foydaga nisbati (davr: 04.07.2022 - 18.11.2026)

Xtant Medical (XTNT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:XTNT Xtant Medical Holdings
xtantmedical.com brendining mahsuloti

Forward P/E aktivning bozor qiymatini kutilayotgan daromadlar nisbatida belgilaydi, bu esa investorlarga spekulyativ shovqinlarni filtrlash va biznesning fundamental haddan tashqari qimmat baholanganligini baholash imkonini beradi. Xtant Medical Holdings (XTNT) uchun konsensus P/E prognozini tahlil qilish orqali, investor XTNT o'sish sur'atlarini umurtqa implantlari bozorining kengayishi va nisha tibbiy aktivlarni absorbsiya qilish samaradorligi bilan solishtiradi, toki haddan tashqari qimmat baholangan aktivda kapital muzlab qolishining oldini olsin.

Xtant Medical Holdings raqobatchilari

Forvard P/E multiplikatori BSX|EW: Narxning kutilayotgan foydaga nisbati|ResMed Corp - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Insulet (PODD)|zimmerbiomet.com - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati CooperCompanies|ALGN: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati ATEC (Alphatec)|Prognoz qilingan narxning foydaga nisbati AORT (Artivion)|ENOV (Enovis Corp) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Integra LifeSciences Inc. IART|ESTA - Prognoz qilingan narxning foydaga nisbati|Beta Bionics, Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati IRADIMED CORPORATION|EMBC: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati TNDM|AXGN (Axogen Surgical) - Forvard P/E multiplikatori|SI-BONE Corp (SIBN) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori OFIX|Forvard P/E multiplikatori bioventus.com (BVS)|Forvard P/E multiplikatori KIDS (OrthoPediatrics Corp)|Forvard P/E multiplikatori Treace Medical Concepts Inc TMCI|SRTA - Kelajakdagi narxning foydaga nisbati|CARL: Kelajakdagi narxning foydaga nisbati|RXST (RxSight, Inc.) - Prognoz qilingan narxning foydaga nisbati|ClearPoint Neuro Inc. - Kelajakdagi narx-foyda multiplikatori|STXS (Stereotaxis Corporation) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Neuronetics Inc. STIM|Kelajakdagi narxning foydaga nisbati Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forvard narx-foyda multiplikatori|Anika Therapeutics Inc. - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori InspireMD, Inc. NSPR|Jin Medical International Ltd. - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Vivani Medical VANI|NeuroOne Medical Technologies Corporation (NMTC) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati MODD (Modular Med)|MYO (Myomo Inc.) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Envoy Medical, Inc. (COCH)|Forvard P/E multiplikatori VVOS|NVNO - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati sintx.com SINT|TNON: Narxning kelajakdagi foydaga nisbati|LFWD: Prognoz qilingan narxning foydaga nisbati|autonomix.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|INVO Bioscience, Inc. (IVF) - Kelajakdagi narxning foydaga nisbati|BBLG (Bone Biologics Corp.) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati AXNX|Biolase Inc. (BIOL) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Dynatronics Corp. (DYNT)|Forvard P/E multiplikatori Paragon 28 (FNA)|Kelajakdagi narxning foydaga nisbati INVO Bioscience INVO